The global downstream processing market size was valued at USD 22.0 Billion in 2021 and it is expected to enjoy a valuation of USD 24.9 Billion by the end of 2022, Furthermore, with rising adoption across biopharmaceutical companies and contract research organizations, the overall demand for downstream processing products is projected to increase at a CAGR of 11.3% between 2022 and 2032, totaling a market valuation of USD72.3 Billion by the year 2032.
Based on product, the chromatography columns and resins segment held around 37.9% share in the global downstream processing market in 2021 and it is likely to retain its dominance even during the projected period (2022 to 2032).
| Attribute | Key Insights |
|---|---|
| Downstream Processing Market Base Value (2021) | USD 22.0 Billion |
| Estimated Market Value (2022) | USD 24.9 Billion |
| Projected Market Value (2032) | USD 72.3 Billion |
| CAGR 2022 to 2032 | 11.3% |
| Market Share of Top 5 Countries | 55.3% |
The manufacturing of pharmaceuticals, food, beverages, and nutraceutical in the present world is largely supported by industrial-scale bioprocessing. The economies of scale and scope that are so heavily reliant on titers, productivity, and product yields are progressively used by these manufacturing processes to increase their profitability.
With a surge in demand for therapeutics, end users like biopharmaceutical companies and contract research organizations are incorporating downstream processing techniques for the development and manufacture of bulk vaccines and other pharmaceutical products.
Government support through research incubators has provided a boost to the development of downstream processing technologies. This has provided a boost to the biopharmaceutical industry’s growth globally which in turn will continue to play a crucial role in expanding the overall downstream processing market size.
Downstream processing is used to manufacture products like antibiotics, vaccines, antibodies, industrial enzymes, and hormones such as insulin. Rising production and consumption of these products due to rising incidences of infectious and chronic diseases like hepatitis, diabetes, dengue, swine flu, etc., will therefore continue to boost the growth of the downstream processing market during the forecast period.
The overall downstream processing market formed approximately 2.2% of the global biotechnology market which stood at USD 1,023.9 Billion in 2021.
The global sales of downstream processing products are projected to grow at 11.3% CAGR between 2022 and 2032, in comparison to the 5.8% CAGR registered during the historical period from 2012 to 2021.
Rising usage of downstream processing techniques for manufacturing various biopharmaceutical products and increasing investments in research and development by pharmaceutical and biopharmaceutical companies are some of the key factors driving the global downstream processing market
Similarly, Rising government funding for basic and clinical research to address real clinical needs, burgeoning demand for biopharmaceuticals, and growing adoption of automation across the pharmaceutical industry is expected to boost the sales of some of the key downstream processing products during the forecast period.
In recent years, biopharmaceutical companies and contract research organizations have ramped up their production of proteins, vaccines, antibodies, and other biopharmaceutical products by employing upstream processes and downstream processing techniques.
The retrieval and purification of biosynthetic products from natural sources, such as plant or animal tissue, is referred to as downstream processing. For example, a crucial step in the production of antibiotics like penicillin is downstream processing.
The method includes separating and purifying antibiotics from a variety of media. Due to the rising need for biologics, downstream technology is increasingly being used in industrial-scale and laboratory applications. This trend is expected to boost downstream processing market growth over the coming years.
Also, the essential force that drives the downstream processing industry is the cumulative demand for biosynthetic products for use in pharmaceutics. Due to their lower risk of side effects, drugs made from naturally occurring sources are currently witnessing increasing demand.
A steady increase in the demand for high-quality pharmaceuticals or recombinant products is expected to drive the downstream processing market at a prolific pace during the forecast period.
Similarly, the rising prevalence of diseases like diabetes, pneumonia, and influenza along with increased awareness of biologics and large molecules is also anticipated to boost demand for downstream techniques during the upcoming years.
Advancements in Downstream Processing to Foster Growth Over the Forthcoming Years
Recently, chromatography adapted to the pharmaceutical industry upon seeing tremendous success in the textile industry, assisting with operations including material preparation and molecular characterization. The downstream processing chromatography industry is experiencing significant advancements with the rise of new therapeutic modalities including monoclonal antibody (mAbs)-based therapeutics.
Pharmaceutical and biopharmaceutical firms are embracing continuous processing, and regulatory bodies support real-time monitoring via process analytical technology (PAT) to control the downstream process. The growth of chromatography systems will also be impacted by the transition from larger, single-product facilities to smaller, multiproduct facilities.
Biopharmaceutical manufacturers are highly focused on effective process control in automation in manufacturing. The pinnacle of intelligence-in-manufacturing, addressed by industry-focused R & D initiatives, is continuously developing through centralized/distributed hardware/software automation systems.
Additionally, the concept of a digital twin for enabling control is shown for a small-scale end-to-end monoclonal antibody production platform. Automation in the manufacturing sector would offer significant opportunities to overcome many constraints to commercial success.
Developers of biotherapeutics must consider large-scale production from the commencement of process development and should incorporate automation techniques. Thus, such advancement will create lucrative opportunities in the downstream processing market.
The cost of separation and purification often makes up more than half of the overall process cost. In order to build a cost-effective bioprocess, the downstream process is carefully examined.
Numerous separation and purification procedures have been combined to achieve the requisite degree of purity, which has increased the cost of the downstream process. Even though the efficiency of each stage is satisfactory, the system's extensive steps result in an increase in equipment costs as well as a reduction in the process' overall separation efficiency.
The monitoring and control of bioprocesses, such as downstream processing, have become more complex as a result of production process advancements, particularly in the biopharmaceutical and nutraceutical industries, and the limitations of some modern and some classical control system techniques are now becoming evident.
The above-mentioned factors pose a restrictive impact on the downstream processing industry and call for prompt attention toward optimization techniques for a smooth process flow.
Increasing Demand for Biopharmaceuticals Fuelling the Sales in the USA
In 2021, the USA held a maximum share of about 90.4% in the North American downstream processing market and it is projected to display a growth rate of 10.5% CAGR during the forecast period (2022 to 2032).
Growth in the USA downstream processing market is driven by rising production and consumption of biopharmaceuticals, favourable government support, the surge in chronic and infectious diseases, and the strong presence of leading end-use industries.
The manufacturers based in the USA are focused on expanding their manufacturing facility to broaden their product portfolio and proposed new avenues for research, and would thus propel the growth of the overall downstream processing industry in this region throughout the forecast period.
For instance, in January 2021, Pall Corporation made significant investments in its global production capacity to meet industry demands driven by six existing manufacturing facilities as well as a new manufacturing facility in the USA
Rising Healthcare Spending Generating Demand in Germany's Downstream Processing Market
Germany held approximately 28.1% market share in the global downstream processing market in 2021 and it is projected to expand at a CAGR of 10.9% during the forecast period.
Rising healthcare spending, government funding for developing bioprocess technology, and rapidly expanding healthcare infrastructure are some of the key factors driving demand for downstream processing products in Germany’s market.
Additionally, the nation has seen significant strategic partnerships with pharmaceutical companies that are heavily investing in the research and development of vaccines and biopharmaceuticals. This will further accelerate the growth of the downstream processing market in Germany during the assessment period.
The surge in the Number of Pharmaceutical Companies in India Driving Growth
India accounted for a market value share of around 52.9% in the South Asia downstream processing market in 2021 and it is poised to exhibit strong growth during the next ten years.
Growth in the Indian downstream processing market is driven by rising production and export of biopharmaceuticals, the large presence of pharmaceutical companies, and increasing healthcare spending due to a surge in chronic and infectious diseases.
Improved product portfolio with process development and modeling of flow during bioprocess, through acquisition and merger activities, has deemed the production of bulk compounds as time-efficient, cost-effective, and with improved quality, even with large quantization of cultures. This has proposed new avenues for research, and would thus propel the growth of the overall bioprocess technology industry throughout the forecast period.
Demand Remains High for Chromatography Columns and Resins
Based on product, the chromatography columns and resins segment dominated the global downstream processing market with a share of around 37.9% in 2021 and it is likely to grow at a robust pace during the forecast period. This can be attributed to the increasing usage of chromatography columns and resins during downstream processing.
Chromatography columns are being increasingly used for the separation of chemical compounds or pharmaceutical compounds while chromatography resins are used to capture and polish mAbs, vaccines, antibody fragments, and other biomolecules.
The constant technological advancement in chromatography, which is considered a dynamic invention in the field of biopharmaceuticals, is predicted to experience positive progress during the forecast timeframe. This in turn will result in the high adoption of products like chromatography columns and resins.
However, the single-use products segment is anticipated to increase at the fastest rate during the coming years.
Purification Remains the Most Widely Used Downstream Processing Technique
The purification segment held a revenue share of around 43.5% in the global downstream processing market in 2021 and it is expected to experience an impressive growth rate of 13.5% during the forecast period. This can be attributed to the rising adoption of purification techniques for getting pure and quality products.
Purification is a key stage technique in downstream processing as it plays a significant role in enhancing the quality of the product and maintaining the purity of the product.
However, the separation segment is anticipated to grow at the fastest rate during the coming years due to the rising adoption of separating various pharmaceutical compounds across various end-use sectors.
Vaccine Production Will Remain the Most Lucrative Application
The vaccine production segment held the highest market share of 30.1% in 2021 and it is expected to grow at a CAGR of 14.5% during the projected period. The growth of this segment is attributed to the development of low-cost and high-quality products like vaccines using downstream purification technologies.
Similarly, the rising incidence of various chronic and infectious diseases and the growing need for improving the immune system of people will indirectly favour the growth of the vaccine production segment during the next ten years.
Most of the Sales to Remain Concentrate on Biopharmaceutical Companies
As per FMI, the biopharmaceutical companies segment held a market share of around 44.0% in 2021 and it is expected to grow at a CAGR of 8.6% during the forecast period. This can be attributed to the rising usage of downstream processing products like chromatography columns & resins, membrane adsorbers, consumables, and single-use products across biopharmaceutical companies.
Biopharmaceutical companies have gained significant traction with expansive strategies to enhance offerings associated with therapeutic and biological use. They are constantly making efforts to improve their productivity by using novel techniques like downstream processing.
Leading players in the downstream processing market are focusing on the development and launch of next-generation downstream processing products. Apart from that, they are concentrating on the expansion of their manufacturing capabilities with high flexibility and rapid operations.
A few of these strategies undertaken by the market players in the downstream processing market are:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | USD 24.9 Billion |
| Projected Market Size (2032) | USD 72.3 Billion |
| Anticipated Growth Rate (2022 to 2032) | 11.3% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, Israel, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Technique, Application, End User, and Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; GE Healthcare; Sartorius Stedim Biotech S.A.; Merck Millipore; Danaher Corporation; 3M Company; Boehringer Ingelheim; Lonza Group AG; Eppendorf AG; Finesse Solutions, Inc.; Bio-Rad Laboratories; Agilent technologies; Solida Biotech GmBH; Waters Corporation; Applikon BioTechnique/Getinge AB |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Table 01: Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 02: Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 03: Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 04: Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 05: Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Region
Table 06: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 07: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 08: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 09: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 10: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 11: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 12: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 13: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 14: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 15: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 16: Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 17: Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 18: Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 19: Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 20: Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 21: East Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 22: East Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 23: East Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 24: East Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 25: East Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 26: South Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 27: South Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 28: South Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 29: South Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 30: South Asia Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 31: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 32: Oceania Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 33: Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 34: Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 35: Oceania Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Table 36: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Country
Table 37: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2032, by Product
Table 38: Middle East & Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Technique
Table 39: Middle East & Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by Application
Table 40: Middle East & Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2032, by End User
Figure 01: Global Market Value (US$ Million) Analysis, 2012 to 2021
Figure 02: Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021 to 2032
Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Product
Figure 06: Global Market Attractiveness Analysis 2022 to 2032, by Product
Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, by Technique
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Technique
Figure 09: Global Market Attractiveness Analysis 2022 to 2032, by Technique
Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, by Application
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Application
Figure 12: Global Market Attractiveness Analysis 2022 to 2032, by Application
Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by End User
Figure 15: Global Market Attractiveness Analysis 2022 to 2032, by End User
Figure 16: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 17: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region
Figure 18: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 19: North America Market Value (US$ Million) Analysis, 2012 to 2021
Figure 20: North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 21: North America Market Value Share, by Product (2022 E)
Figure 22: North America Market Value Share, by Technique (2022 E)
Figure 23: North America Market Value Share, by Application (2022 E)
Figure 24: North America Market Value Share, by End User (2022 E)
Figure 25: North America Market Value Share, by Country (2022 E)
Figure 26: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 27: North America Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 28: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 30: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 31: USA Market Value Proportion Analysis, 2021
Figure 32: Global Vs.The USA Growth Comparison, 2021 to 2032
Figure 33: USA Market Share Analysis (%) by Product, 2021 to 2032
Figure 34: USA Market Share Analysis (%) by Technique, 2021 to 2032
Figure 35: USA Market Share Analysis (%) by Application, 2021 to 2032
Figure 36: USA Market Share Analysis (%) by End User, 2021 to 2032
Figure 37: Canada Market Value Proportion Analysis, 2021
Figure 38: Global Vs. Canada Growth Comparison, 2021 to 2032
Figure 39: Canada Market Share Analysis (%) by Product, 2021 to 2032
Figure 40: Canada Market Share Analysis (%) by Technique, 2021 to 2032
Figure 41: Canada Market Share Analysis (%) by Application, 2021 to 2032
Figure 42: Canada Market Share Analysis (%) by End User, 2021 to 2032
Figure 43: Latin America Market Value (US$ Million) Analysis, 2012 to 2021
Figure 44: Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 45: Latin America Market Value Share, by Product (2022 E)
Figure 46: Latin America Market Value Share, by Technique (2022 E)
Figure 47: Latin America Market Value Share, by Application (2022 E)
Figure 48: Latin America Market Value Share, by End User (2022 E)
Figure 49: Latin America Market Value Share, by Country (2022 E)
Figure 50: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 51: Latin America Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 52: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 53: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 54: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 55: Mexico Market Value Proportion Analysis, 2021
Figure 56: Global Vs Mexico Growth Comparison, 2021 to 2032
Figure 57: Mexico Market Share Analysis (%) by Product, 2021 to 2032
Figure 58: Mexico Market Share Analysis (%) by Technique, 2021 to 2032
Figure 59: Mexico Market Share Analysis (%) by Application, 2021 to 2032
Figure 60: Mexico Market Share Analysis (%) by End User, 2021 to 2032
Figure 61: Brazil Market Value Proportion Analysis, 2021
Figure 62: Global Vs. Brazil. Growth Comparison, 2021 to 2032
Figure 63: Brazil Market Share Analysis (%) by Product, 2021 to 2032
Figure 64: Brazil Market Share Analysis (%) by Technique, 2021 to 2032
Figure 65: Brazil Market Share Analysis (%) by Application, 2021 to 2032
Figure 66: Brazil Market Share Analysis (%) by End User, 2021 to 2032
Figure 67: Argentina Market Value Proportion Analysis, 2021
Figure 68: Global Vs Argentina Growth Comparison, 2021 to 2032
Figure 69: Argentina Market Share Analysis (%) by Product, 2021 to 2032
Figure 70: Argentina Market Share Analysis (%) by Technique, 2021 to 2032
Figure 71: Argentina Market Share Analysis (%) by Application, 2021 to 2032
Figure 72: Argentina Market Share Analysis (%) by End User, 2021 to 2032
Figure 73: Europe Market Value (US$ Million) Analysis, 2012 to 2021
Figure 74: Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 75: Europe Market Value Share, by Product (2022 E)
Figure 76: Europe Market Value Share, by Technique (2022 E)
Figure 77: Europe Market Value Share, by Application (2022 E)
Figure 78: Europe Market Value Share, by End User (2022 E)
Figure 79: Europe Market Value Share, by Country (2022 E)
Figure 80: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 81: Europe Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 82: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 83: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 84: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 85: UK Market Value Proportion Analysis, 2021
Figure 86 Global Vs. UK Growth Comparison, 2021 to 2032
Figure 87: UK Market Share Analysis (%) by Product, 2021 to 2032
Figure 88: UK Market Share Analysis (%) by Technique, 2021 to 2032
Figure 89: UK Market Share Analysis (%) by Application, 2021 to 2032
Figure 90: UK Market Share Analysis (%) by End User, 2021 to 2032
Figure 91: Germany Market Value Proportion Analysis, 2021
Figure 92: Global Vs. Germany Growth Comparison, 2021 to 2032
Figure 93: Germany Market Share Analysis (%) by Product, 2021 to 2032
Figure 94: Germany Market Share Analysis (%) by Technique, 2021 to 2032
Figure 95: Germany Market Share Analysis (%) by Application, 2021 to 2032
Figure 96: Germany Market Share Analysis (%) by End User, 2021 to 2032
Figure 97: Italy Market Value Proportion Analysis, 2021
Figure 98: Global Vs. Italy Growth Comparison, 2021 to 2032
Figure 99: Italy Market Share Analysis (%) by Product, 2021 to 2032
Figure 100: Italy Market Share Analysis (%) by Technique, 2021 to 2032
Figure 101: Italy Market Share Analysis (%) by Application, 2021 to 2032
Figure 102: Italy Market Share Analysis (%) by End User, 2021 to 2032
Figure 103: France Market Value Proportion Analysis, 2021
Figure 104: Global Vs France Growth Comparison, 2021 to 2032
Figure 105: France Market Share Analysis (%) by Product, 2021 to 2032
Figure 106: France Market Share Analysis (%) by Technique, 2021 to 2032
Figure 107: France Market Share Analysis (%) by Application, 2021 to 2032
Figure 108: France Market Share Analysis (%) by End User, 2021 to 2032
Figure 109: Spain Market Value Proportion Analysis, 2021
Figure 110: Global Vs Spain Growth Comparison, 2021 to 2032
Figure 111: Spain Market Share Analysis (%) by Product, 2021 to 2032
Figure 112: Spain Market Share Analysis (%) by Technique, 2021 to 2032
Figure 113: Spain Market Share Analysis (%) by Application, 2021 to 2032
Figure 114: Spain Market Share Analysis (%) by End User, 2021 to 2032
Figure 115: Russia Market Value Proportion Analysis, 2021
Figure 116: Global Vs Russia Growth Comparison, 2021 to 2032
Figure 117: Russia Market Share Analysis (%) by Product, 2021 to 2032
Figure 118: Russia Market Share Analysis (%) by Technique, 2021 to 2032
Figure 119: Russia Market Share Analysis (%) by Application, 2021 to 2032
Figure 120: Russia Market Share Analysis (%) by End User, 2021 to 2032
Figure 121: BENELUX Market Value Proportion Analysis, 2021
Figure 122: Global Vs BENELUX Growth Comparison, 2021 to 2032
Figure 123: BENELUX Market Share Analysis (%) by Product, 2021 to 2032
Figure 124: BENELUX Market Share Analysis (%) by Technique, 2021 to 2032
Figure 125: BENELUX Market Share Analysis (%) by Application, 2021 to 2032
Figure 126: BENELUX Market Share Analysis (%) by End User, 2021 to 2032
Figure 127: East Asia Market Value (US$ Million) Analysis, 2012 to 2021
Figure 128: East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 129: East Asia Market Value Share, by Product (2022 E)
Figure 130: East Asia Market Value Share, by Technique (2022 E)
Figure 131: East Asia Market Value Share, by Application (2022 E)
Figure 132: East Asia Market Value Share, by End User (2022 E)
Figure 133: East Asia Market Value Share, by Country (2022 E)
Figure 134: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 135: East Asia Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 136: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 137: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 138: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 139: China Market Value Proportion Analysis, 2021
Figure 140: Global Vs. China Growth Comparison, 2021 to 2032
Figure 141: China Market Share Analysis (%) by Product, 2021 to 2032
Figure 142: China Market Share Analysis (%) by Technique, 2021 to 2032
Figure 143: China Market Share Analysis (%) by Application, 2021 to 2032
Figure 144: China Market Share Analysis (%) by End User, 2021 to 2032
Figure 145: Japan Market Value Proportion Analysis, 2021
Figure 146: Global Vs. Japan Growth Comparison, 2021 to 2032
Figure 147: Japan Market Share Analysis (%) by Product, 2021 to 2032
Figure 148: Japan Market Share Analysis (%) by Technique, 2021 to 2032
Figure 149: Japan Market Share Analysis (%) by Application, 2021 to 2032
Figure 150: Japan Market Share Analysis (%) by End User, 2021 to 2032
Figure 151: South Korea Market Value Proportion Analysis, 2021
Figure 152: Global Vs South Korea Growth Comparison, 2021 to 2032
Figure 153: South Korea Market Share Analysis (%) by Product, 2021 to 2032
Figure 154: South Korea Market Share Analysis (%) by Technique, 2021 to 2032
Figure 155: South Korea Market Share Analysis (%) by Application, 2021 to 2032
Figure 156: South Korea Market Share Analysis (%) by End User, 2021 to 2032
Figure 157: South Asia Market Value (US$ Million) Analysis, 2012 to 2021
Figure 158: South Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 159: South Asia Market Value Share, by Product (2022 E)
Figure 160: South Asia Market Value Share, by Technique (2022 E)
Figure 161: South Asia Market Value Share, by Application (2022 E)
Figure 162: South Asia Market Value Share, by End User (2022 E)
Figure 163: South Asia Market Value Share, by Country (2022 E)
Figure 164: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 165: South Asia Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 166: South Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 167: South Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 168: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 169: India Market Value Proportion Analysis, 2021
Figure 170: Global Vs. India Growth Comparison, 2021 to 2032
Figure 171: India Market Share Analysis (%) by Product, 2021 to 2032
Figure 172: India Market Share Analysis (%) by Technique, 2021 to 2032
Figure 173: India Market Share Analysis (%) by Application, 2021 to 2032
Figure 174: India Market Share Analysis (%) by End User, 2021 to 2032
Figure 175: Indonesia Market Value Proportion Analysis, 2021
Figure 176: Global Vs. Indonesia Growth Comparison, 2021 to 2032
Figure 177: Indonesia Market Share Analysis (%) by Product, 2021 to 2032
Figure 178: Indonesia Market Share Analysis (%) by Technique, 2021 to 2032
Figure 179: Indonesia Market Share Analysis (%) by Application, 2021 to 2032
Figure 180: Indonesia Market Share Analysis (%) by End User, 2021 to 2032
Figure 181: Malaysia Market Value Proportion Analysis, 2021
Figure 182: Global Vs. Malaysia Growth Comparison, 2021 to 2032
Figure 183: Malaysia Market Share Analysis (%) by Product, 2021 to 2032
Figure 184: Malaysia Market Share Analysis (%) by Technique, 2021 to 2032
Figure 185: Malaysia Market Share Analysis (%) by Application, 2021 to 2032
Figure 186: Malaysia Market Share Analysis (%) by End User, 2021 to 2032
Figure 187: Thailand Market Value Proportion Analysis, 2021
Figure 188: Global Vs. Thailand Growth Comparison, 2021 to 2032
Figure 189: Thailand Market Share Analysis (%) by Product, 2021 to 2032
Figure 190: Thailand Market Share Analysis (%) by Technique, 2021 to 2032
Figure 191: Thailand Market Share Analysis (%) by Application, 2021 to 2032
Figure 192: Thailand Market Share Analysis (%) by End User, 2021 to 2032
Figure 193: Oceania Market Value (US$ Million) Analysis, 2012 to 2021
Figure 194: Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 195: Oceania Market Value Share, by Product (2022 E)
Figure 196: Oceania Market Value Share, by Technique (2022 E)
Figure 197: Oceania Market Value Share, by Application (2022 E)
Figure 198: Oceania Market Value Share, by End User (2022 E)
Figure 199: Oceania Market Value Share, by Country (2022 E)
Figure 200: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 201: Oceania Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 202: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 203: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 204: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 205: Australia Market Value Proportion Analysis, 2021
Figure 206: Global Vs. Australia Growth Comparison, 2021 to 2032
Figure 207: Australia Market Share Analysis (%) by Product, 2021 to 2032
Figure 208: Australia Market Share Analysis (%) by Technique, 2021 to 2032
Figure 209: Australia Market Share Analysis (%) by Application, 2021 to 2032
Figure 210: Australia Market Share Analysis (%) by End User, 2021 to 2032
Figure 211: New Zealand Market Value Proportion Analysis, 2021
Figure 212: Global Vs New Zealand Growth Comparison, 2021 to 2032
Figure 213: New Zealand Market Share Analysis (%) by Product, 2021 to 2032
Figure 214: New Zealand Market Share Analysis (%) by Technique, 2021 to 2032
Figure 215: New Zealand Market Share Analysis (%) by Application, 2021 to 2032
Figure 216: New Zealand Market Share Analysis (%) by End User, 2021 to 2032
Figure 217: Middle East & Africa Market Value (US$ Million) Analysis, 2012 to 2021
Figure 218: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032
Figure 219: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 220: Middle East & Africa Market Value Share, by Technique (2022 E)
Figure 221: Middle East & Africa Market Value Share, by Application (2022 E)
Figure 222: Middle East & Africa Market Value Share, by End User (2022 E)
Figure 223: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 224: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 225: Middle East & Africa Market Attractiveness Analysis by Technique, 2022 to 2032
Figure 226: Middle East & Africa Market Attractiveness Analysis by Application, 2022 to 2032
Figure 227: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2032
Figure 228: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 229: GCC Countries Market Value Proportion Analysis, 2021
Figure 230: Global Vs GCC Countries Growth Comparison, 2021 to 2032
Figure 231: GCC Countries Market Share Analysis (%) by Product, 2021 to 2032
Figure 232: GCC Countries Market Share Analysis (%) by Technique, 2021 to 2032
Figure 233: GCC Countries Market Share Analysis (%) by Application, 2021 to 2032
Figure 234: GCC Countries Market Share Analysis (%) by End User, 2021 to 2032
Figure 235: Turkey Market Value Proportion Analysis, 2021
Figure 236: Global Vs. Turkey Growth Comparison, 2021 to 2032
Figure 237: Turkey Market Share Analysis (%) by Product, 2021 to 2032
Figure 238: Turkey Market Share Analysis (%) by Technique, 2021 to 2032
Figure 239: Turkey Market Share Analysis (%) by Application, 2021 to 2032
Figure 240: Turkey Market Share Analysis (%) by End User, 2021 to 2032
Figure 241: South Africa Market Value Proportion Analysis, 2021
Figure 242: Global Vs. South Africa Growth Comparison, 2021 to 2032
Figure 243: South Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 244: South Africa Market Share Analysis (%) by Technique, 2021 to 2032
Figure 245: South Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 246: South Africa Market Share Analysis (%) by End User, 2021 to 2032
Figure 247: North Africa Market Value Proportion Analysis, 2021
Figure 248: Global Vs North Africa Growth Comparison, 2021 to 2032
Figure 249: North Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 250: North Africa Market Share Analysis (%) by Technique, 2021 to 2032
Figure 251: North Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 252: North Africa Market Share Analysis (%) by End User, 2021 to 2032
The global downstream processing market is expected to reach USD 24.9 Billion in 2022.
The downstream processing market is expected to reach USD 72.3 Billion by the end of 2032, with overall sales likely to grow at 11.3% CAGR throughout the forecast period.
The rising adoption of single-use (disposable) bioprocessing technology, reduction in operating costs due to continuous bioprocessing, an increase in the use of next-generation computing technology in biotech, and surge in the use of biosimilars are the key trends shaping the downstream processing industry.
The USA, Germany, China, Japan, and India are the top five countries driving demand for downstream processing products.
North American held a market share of around 33.6% in the global downstream processing market in 2021.
The MEA downstream processing market is expected to register a CAGR of 11.2% during the forecast period.
The downstream processing market in Japan is expected to grow at a CAGR of 18.4% during the forecast period.
From 2012 to 2021, the global downstream processing market expanded at 5.8% CAGR.
The downstream processing market in India is likely to grow at a CAGR of 18.6% during the forecast period.
Thermo Fisher Scientific Inc., Danaher Corporation (Pall Biotech and Cytiva), Merck KGaA are the key players in the downstream processing market.
Explore Life Science & Biotechnology Insights
Downstream Processing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
